LERIGLITAZONE HYDROCHLORIDE
UNII WN9K42SAM6

Substance Identification & Data

This profile provides standardized clinical and technical data for Leriglitazone Hydrochloride, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WN9K42SAM6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 146062-46-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

WN9K42SAM6

CAS Registry Number

146062-46-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LERIGLITAZONE HYDROCHLORIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C19H20N2O4S.ClH

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

SBHOQYCDAHAMDW-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C174935

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

86748889

Unique identification number in the NCBI database of chemical substances.

USAN ID

GH-66

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1(NC(=O)C(Cc2ccc(OCCc3ccc(C(O)C)cn3)cc2)S1)=O.Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Leriglitazone Hydrochloride. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.